Skip to main content
Caplight Logo









Genosco

Genosco

Private
Billerica, MassachusettsHealthcare & Life Scienceshttp://genosco.com/

Last Round

VC Round

Apr 1, 2016

Total Funding Raised

$7.65M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Genosco is a biotechnology company that discovers and develops novel small-molecule drugs for patients with unmet medical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

small molecule discoverykinase inhibitorsdrug out-licensingclinical stage biotechasset-centric biotechoncology drug discoveryimmunology drug discoveryEGFR inhibitorstargeted protein degradationTPDdrug discovery enginebrain-penetrant TKInon-small cell lung cancerNSCLCSYK inhibitormolecular glue degradersimmune thrombocytopeniaITP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genosco Comparables

Compare Genosco with similar companies based on industry and business-model similarity.

Genosco comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Oscotec Inc
88%
Redx Pharma Plc
81%
AstraZeneca
77%

Genosco Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 1, 2016

Key People

Founding team and executive leadership

SEWON KIM

Deputy Chief Technology Officer

Executive Team

yong yang

CFO

Executive Team

Genosco Investors

Notable investors and investment history

Genosco investors
InvestorRounds
Meritz Securities Co., Ltd.Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 54% MoM.

  • Jun 22, 2026

    Monthly visitors increased 291% MoM.

Genosco Filings

Explore SEC and related filing metadata, where available.

Genosco filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genosco's valuation, stock price, and market status.

Is Genosco a public or private company?

Genosco is a private company.

What is the current stock price of Genosco?

Genosco is a private company with no public stock price. No recent secondary market data is available.

How much is Genosco worth (valuation)?

Valuation information for Genosco is not publicly available.

Can I buy Genosco stock?

Genosco shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genosco's last funding round?

Genosco's most recent funding round was VC Round on April 1, 2016.

Who are the main investors in Genosco?

Key investors in Genosco include Meritz Securities Co., Ltd..

Will Genosco IPO soon?

No public IPO plans have been announced for Genosco.

How can I track Genosco secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genosco's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBillerica, Massachusetts
Employee Range17
Year Founded2000
Last FundingApr 1, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?